American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer.

@article{Loblaw2004AmericanSO,
  title={American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer.},
  author={D. Andrew Loblaw and David S. Mendelson and James Austin Talcott and Katherine S. Virgo and Mark R. Somerfield and Edgar Ben-Josef and Richard Middleton and Henry Porterfield and Stewart A Sharp and Thomas James Smith and Mary Ellen Taplin and Nicholas John Vogelzang and James Lloyd Wade and Charles L Bennett and Howard I. Scher},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2004},
  volume={22 14},
  pages={2927-41}
}
PURPOSE To develop a clinical practice guideline for the management of men with metastatic, recurrent, or progressive carcinoma of the prostate. The focus of this document is on the use, combinations, and timing of various forms of androgen deprivation therapy (ADT) for the palliation of men with androgen-sensitive disease. METHODS An expert panel and writing committee were formed. The questions to be addressed by the guideline were determined, and a systematic review of the literature was… CONTINUE READING
52 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 52 extracted citations

Similar Papers

Loading similar papers…